Effects of the RV3466F Lotion on Female Telogen Effluvium: Results from a 16-Week, Multi-Centric, Controlled, Randomized Trial

The document detailed a 16-week study on the effectiveness of RV3466F lotion in treating acute telogen effluvium in 100 women aged 19 to 50. The lotion, containing creatin, acetyl tetrapeptide, and vitamins, was applied three times weekly. Measurements using phototrichogram, 60 seconds hair count test, standardized photographs, and questionnaires indicated a significant reduction in telogen hair density and shedding, especially at the 8-week mark, and an increase in the anagen to telogen ratio, compared to a control group. The study concluded that RV3466F lotion significantly reduces hair loss and helps resolve acute telogen effluvium, while being dermatologically safe.